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Background: Various genospecies of Borrelia burgdorferi sensu lato (s.l.) have been identified from patients and
animals worldwide. Genospecies-related dissemination of disease has been reported. The present study aimed to
elucidate the pathogenicity of infections caused by B. garinii SZ isolated in China. B. burgdorferi B31 and B. afzelii
BO23 were used for comparison.
Methods: Spirochete load in blood and tissue samples of infected mice were measured by minor groove
binder-based real-time polymerase chain reaction. The kinetics of spirochete dissemination and disease severity
were assessed in BALB/c mice.
Results: The pattern of bacterial load differed between the three genospecies. The B. garinii SZ strain is highly
pathogenic and can trigger multi-system pathological damage in mice.
Conclusions: Spirochete dissemination, persistence, tissue tropism and disease severity varied significantly,
suggesting that different genospecies may play an important role in the pathogenicity and development of clinical
diseases.
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The Borrelia burgdorferi s.l. complex comprises 18
known Borrelia genotypes. Three of them predominate
as human pathogens: B. burgdorferi sensu stricto (s.s.),
B. garinii (including B. garinii OspA type 4, recently
designated B. bavariensis) and B. afzelii [1]. However, B.
valaisiana, B. lusitaniae, B. spielmanii and B. bissettii,
have been also occasionally isolated or detected in pa-
tient specimens [2,3]. The symptoms and severity of the
disease vary in B. burgdorferi genospecies. B. garinii is
primarily associated with neuroborreliosis [4], B. afzelii
with acrodermatitis chronic athrophicans [5] and B.
burgdorferi s.s is prevalent in Lyme arthritis [6].
Examination of the relationship between genospecies
and clinical symptoms using real-time polymerase chain
reaction (PCR) to detect B. burgdorferi levels in all tis-
sues of C3H/HeJ mice and BALB/c mice reported a
positive correlation between clinical symptoms (arthritis)* Correspondence: ljxbn@163.com; yinhong@caas.net.cn
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reproduction in any medium, provided the orand spirochete burden [7]. The correlation of B.
burgdorferi genospecies with clinical presentation is po-
tentially valuable in explaining the disease manifestations
of Lyme borreliosis [8]. Numerous new isolates of B.
burgdorferi have been obtained. However, the pathogen-
icity of these isolates is unclear.
B. garinii is the main genotype found in China [9]. To
elucidate the pathogenicity of the B. garinii SZ isolated
in China, the kinetics of spirochete dissemination and
the severity of the disease were evaluated in a murine
model. Considering that different genotypes of B.
burgdorferi could potentially affect disease pathogenicity,
B. burgdorferi B31 and B. afzelii BO23 were used for
comparison. Dissemination of spirochetes in blood and
tissues was evaluated using TaqMan™ minor groove
binder (MGB) - real time polymerase chain reaction
(PCR) and disease severity was assessed by histopatho-
logic assessment of inflammatory cell infiltrates and the
extent of tissue necrosis.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Bacterial strains
B. burgdorferi B31 and B. afzelii BO23 were purchased
from ATCC (Manassas, VA) and were passaged five times
in vitro. B. garinii SZ was isolated from Dermacentor ticks
collected in Shangzhi County of Heilongjiang Province,
China [10]. These strains were incubated in BSK-H
medium at 33°C and observed with a dark-field micro-
scope every other day. The bacteria were harvested by
centrifugation at 5,000 g when they reached logarithmic
phase and were washed twice with phosphate buffered
saline (PBS). The suspension was adjusted to a density
containing 105 cells/ml using a Petroff-Hausser counting
chamber.
Mice and infection
Female specific pathogen-free BALB/c mice were
obtained from the Breeding Laboratory, Lanzhou Veter-
inary Research Institute (Lanzhou, China). All mice were
4 weeks old at the time of infection. The mice were di-
vided randomly into control, SZ, BO23 and B31 groups
each consisting of 25 mice. Mice in the experimental
groups received an intraperitoneal injection of 200 μl
PBS containing 105/ml of B. burgdorferi cells in experi-
mental groups. Control mice were injected with 200 μl
PBS. Tissue specimens from blood, brain, tongue, heart,
lung, liver, spleen, kidney, lymph, bladder, joints and skin
were collected on days 2, 5, 9, 15, 30, 60, 90 and 150
after infection.
DNA preparation
DNA was prepared using the QiaAmp tissue kit and
Puregene blood core kit (Qiagen, Valencia, CA) follow-
ing the manufacturer’s instructions. The DNA was fi-
nally eluted in 200 μl distilled water and stored at −20°C
until use.
Real-time PCR
Simultaneous detection and quantification of B.
burgdorferi DNA were performed in a model MX3000 P
real-time PCR machine (Stratagene, La Jolla, CA). The
targeting gene was the flaB single copy gene [11]. The
TaqMan™ MGB-probe and corresponding primers were
designed using Primer Express™ software (Applied
Biosystems, Foster City, CA). The upstream primer was
5′-GTG CAT TTG GTT ATA TTG AG-3′, the down-
stream primer was 5′-CAG ACA GAG GTT CTA TAC
A-3′ and the probe was FAM-5′AAT AGA GCA ACT
TAC AGA-3′-MGB. The probe was purchased from Ap-
plied Biosystems and the primers were from Shanghai
Shenggong (Shanghai, China).
For quantitation of the mouse host, β-actin was
chosen. The upstream primer was 5′-AGA GGG AAA
TCG TGC GTG AC-3′, the downstream primer was 5′-CAA TAG TGA TGA CCT GGC CGT-3′ and the
TaqMan™ probe was FAM-5′CAC GGC CGC ATC CTC
TTC TTC C-BHQ1-3′.
The plasmids containing the flaB gene of B.
burgdorferi B31 and mouse β-actin gene served as stan-
dards. The plasmid containing 1100 bp flaB gene was
obtained by PCR amplification using the flaB upstream
primer 5′-ATG ATT ATC AAT CAT AAT ACA TCA-3′
and downstream primer 5′-TTA TCT AAG CAA TGA
CAA-3′. The PCR fragment was cloned into the pGEM-
T vector (Promega, Madison, WI) and then propagated
in competent Escherichia coli JM109 (TaKaRa, Dalian,
China). The plasmid containing the 129 bp β-actin gene
was obtained by PCR amplification using the upstream
primer 5′-AGA GGG AAA TCG TGC GTG AC-3′ and
the downstream primer 5′-CAA TAG TGA TGA CCT
GGC CGT-3′ and cloned as described above. Plasmid
DNA was quantified using a model 2000 spectropho-
tometer (NanoDrop Technologies, Wilmington, DE).
The plasmid control in the real-time PCR was to ensure
the efficacy of the assay and to compile standard curves
for determination of the flaB copy number in mouse tis-
sue. Ten-fold serial plasmid dilutions were prepared,
ranging from 100-107 copies.
The PCR mixture (25 μl total volume) consisted of
300 nM primer, 200 nM probe, 200 nM deoxynucleoside
triphosphates, 3.5 mM MgCl2, 2 μl DNA, 1 U AmpliTaq
Gold and 1 × PCR buffer. Amplification and detection
were performed using 40 cycles 95°C for 10 s, 57°C for
30 s (flaB) and 95°C for 10 s and 60°C for 30 s (β-actin).
Actin and flaB PCR used separate reaction mixtures.
The FAM signal was standardized to the passive refer-
ence ROX, which was included in the reaction buffer.
Individual samples were run in triplicate.
Histopathologic analysis
On days 30, 60 and 90 after infection, three mice in
each group (total 12) were sacrificed. Brain, heart,
lung, liver, kidney, spleen and joint tissues were
obtained and immersed in formalin. Tissues were em-
bedded in paraffin, sectioned at a thickness of 5 μm
and stained with hematoxylin and eosin (H&E). Each
histopathologic parameter was assessed and scored separ-
ately by two pathologists using a semi-quantitative
criteria-based scoring method [12]. Scores of 0 (ab-
sent,-), 0–10 (mild,+), 10–20 (moderate,++) and 20–30
(severe,+++) were assigned to each parameter, and the
average scores were used to reflect the overall severity
for each group of mice.
Statistical analysis
Quantitative data obtained by real-time PCR were ana-
lyzed using Prism and Excel 97 software. Significant dif-
ferences were determined by unpaired Student’s t test
Table 1 Spirochete burden in blood infected by different
strains at different times post-infection (p.i.)a
Time p.i B31 SZ BO23 Control
2 d 263 153 278 0
5 d 329 105 558 0
9 d 1260 160 1060 0
15 d 258 875 250 0
30 d 366 759 136 0
60 d 144 129 89 0
90 d 0 0 0 0
a BALB/c mice were sacrificed at various time points after infection. The blood
was tested for Borrelia by qPCR. The mean numbers of spirochetes per 106
mouse cells (calculated on the basis of β-actin standard curves) are given.
days (d).
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Ethical approval
The animal experiments in this research were approved
by Gansu Provincial Science and Technology depart-
ment in China and in accordance with the Animal
House of Lanzhou Veterinary Research Institute Instruc-
tions. The license No: SYXK2010-0001.
Results
Detection and quantification of B. burgdorferi in mouse
tissues
Two microliters of mouse DNA or external standard
template containing 100-107 copies of B. burgdorferi flaB
were used. Therefore, the theoretical number of bacteria
in our sample was 100 times lower. All mice infected
with B31 and SZ became B. burgdorferi positive, whereas
B. afzelii BO23 failed to establish an infection. Spiro-
chetes in the blood, brain, tongue, heart, lung, liver,
spleen, kidney, lymph, bladder, joint and skin tissues
were collected from mice infected with B. burgdorferi
B31, B. afzelii BO23 and B. garinii SZ 2, 5, 9, 15, 30, 60,
90 and 150 days after infection (Additional file 1: TableFigure 1 Kinetic distribution of spirochetes in tissues of mice. BALB/c
heart, liver and spleen tissues were tested for Borrelia by qPCR. (A): B. burgd
106 mouse cells (calculated on the basis ofβ-actin standard curves) are giveS1 and Table 1). Spirochete DNA was detected by qPCR
in all tissues according to time course during infection;
the overall patterns of bacterial load followed a fluctu-
ated trend among the isolates during the 30 days after
infection. For mice infected with B. burgdorferi B31, a
relatively higher spirochete burden in tissues was
reached at 2 days after infection, peaking on day 5, grad-
ually subsiding from days 5 to 9 and then gradually re-
covering from day 15 to day 30 (Figure 1A). B. garinii
SZ numbers were greater at day 5, peaked at day 9, and
gradually subsided through day 15 (Figure 1B). On day
30 after infection, B. burgdorferi B31 produced the more
consistent and higher spirochete burden than SZ. Sixty
days after infection, the differences in the numbers of
spirochetes between tissues from the two Borrelia
genospecies strains became smaller but the persistent
tissue tropism was significantly different. On days 90
and 150 after infection, persistence of Borrelia was evi-
dent in spleens of B31 infected mice and in livers of SZ
infected mice (Additional file 1: Table S1). The number
of spirochetes in blood was lower compared with other
tissues at the indicated times (Table 1).
Severity of disease assessed by histopathologic analysis
Histopathology of mice infected with B. burgdorferi B31,
B. garinii SZ and B. afzelii BO23 on days 30, 60 and 90
after infection was studied. The differences in disease se-
verity between B31 and SZ infected mice were signifi-
cant in brain, heart, liver and spleen tissues (p < 0.05)
30 days after infection (Table 2, Figure 2). No significant
pathologic abnormality was observed in BO23 infected
mice and no pathologic abnormality was observed in
any tissues of control mice.
Discussion
There are at least five Borrelia genotypes (B. burgdorferi
s.s, B. garinii, B. afzelii, B. valaisiana and B. sinica) in
China, and B. burgdorferi s.s, B. garinii and B. afzelii
have been reported as the main pathogenic genotypesmice were sacrificed at various time points after infection. The brain,
orferi B31 and (B): B. garinii SZ. The mean numbers of spirochetes per
n.
Table 2 Severity of tissue damage caused by different Borrelia strains a
Day 30 after infection Day 60 after infection Day 90 after infection
B31 SZ BO23 B31 SZ B31 SZ Control
Brain ++ +++ — ++ ++ + ++ —
Heart ++ +++ — ++ ++ + ++ —
Lung ++ ++ — + + + + —
Liver +++ ++ — +++ ++ +++ + —
Spleen +++ ++ — ++ ++ ++ ++ —
Kidney +++ +++ — +++ ++ ++ + —
Joint ++ ++ — + + + — —
a +++ severe, ++ moderate, + mild,—absent.
Three mice in each group were sacrificed at 30, 60, and 90 days after inoculation. Disease severity was assessed by histopathologic assessment of inflammatory
cell infiltrates and necrosis extent in tissues. The differences in disease severity between B31 and SZ infected mice were significant in brain, heart, liver and spleen
tissues (P <0.05) at 30 days after inoculation. At 60 and 90 days after inoculation, there were varying degrees of recovery.
Figure 2 Severity of tissue damage caused by different Borrelia
strains 30 days post infection. Each histopathologic parameter
was assessed and scored separately by a semi-quantitative criteria-
based scoring method [12]. The average scores were used to reflect
the overall severity for each group of mice. The differences in
disease severity between B31 and SZ infected mice were significant
in brain, heart, liver and spleen tissues (p < 0.05). The asterisks
indicate samples whose values are statistically significantly different
between B31 and SZ (*, P <0.05; **, P <0.01; ***, P <0.001). Error bars
indicate standard deviations.
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genotype in China [9]. B. garinii SZ isolated from
Dermacentor ticks collected in Shangzhi County of
Heilongjiang Province in China is very similar to B. garinii
strain DK27 isolated from Denmark and B. garinii Khab
isolated from France in terms of the morphology and
molecular characteristics [10]. As the presence of B.
burgdorferi species in Dermacentor ticks has been widely
noted, but vector competence appears to be very poor
[14]. When B. burgdorferi B31 low passage strain spiro-
chetes were directly injected into the hemocoel of
Dermacentor variabilis, the bacteria were cleared early
[15]. However, the occasional human cases of Lyme
disease in Indiana were observed from Dermacentor
variabilis ticks [16] and the epidemiology of tick-
borne pathogens infecting Dermacentor spp. in France
has been reported [17]. Hence, they are often omitted
from the Dermacentor tick investigations. The present
study assessed the pathogenicity of B. garinii SZ in a
murine model.
Evidence from real-time PCR and histopathology indi-
cated that B. burgdorferi B31 and B. garinii SZ could
disseminate to different interior tissues 2 days after in-
fection. This is inconsistent with the previously reported
findings in C3H and BALB/c mice infected with B.
burgdorferi B31, in which the bacteria were initially
detected in organs 8–15 days after infection [7,18]. Dis-
semination of the bacteria as early as 2 days after experi-
mental infection in mice has been reported [19]. This
difference can be attributed to the routes of infection,
host factors and detection methods of the bacterial bur-
den [20,21]. The presence of Borrelia in target tissues
and consequent interactions with the host play a role in
promoting host inflammation and affect the clinical
presentation of disease [12]. Presently, differences in dis-
ease severity between B. burgdorferi B31 and B. garinii
SZ infected mice were significant in brain, heart, liver
and spleen tissues at 30 days after inoculation. Thedifference in the clinical manifestation was highly corre-
lated with the difference of the spirochete burden. This
phenomenon was also observed by other authors [18].
In B31 infected mice, spirochetes persisted in the kidney.
In SZ infected mice, spirochetes persisted in the liver
and spleen. These findings might provide a reference for
epidemiological investigation of the field samples. The
present observation of infections lasting up to 6 months
was consistent with prior results [22].
Although bloodstream invasion is an important route,
evidence from the real-time PCR indicated that blood
spirochete burden in mice infected with the three
genospecies of Borrelia strains was low. A previous
study used a nested and quantitative polymerase chain
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in the plasma of untreated early Lyme disease patients
with erythema migrans; the number of flaB gene copies
did not significantly correlate with any of the clinical,
demographic or laboratory variables assessed (8), which
may be an important factor in explaining why some
spirochetemic patients are completely asymptomatic
[23]. However, another study reported that the bacterial
burden in blood was significantly correlated with disease
severity [12], with the peak number observed 4–7 days
after infection. This may explain why some infected pa-
tients have only subclinical disease, whereas others de-
velop overt manifestations.
Signs and symptoms of putative failure of BO23 infec-
tion in mice or ineffectiveness of infection with BO23
may be formally attributed to the mouse species; it is
possible that not all species of mice are susceptible to
disseminated infection by B. burgdorferi isolates. Vari-
able host susceptibility to different B. burgdorferi isolates
and complement sensitivity among different Borrelia
species has been reported [24].
Conclusions
The present study aimed to determine the pathogenicity
of B. garinii SZ, in which B. burgdorferi B31 and B.
afzelii BO23 were used for comparison. The data
obtained by real-time PCR and the histopathology indi-
cated the correlations of spirochete burden and disease
severity in mouse tissues in infections caused by B.
garinii SZ, B. burgdorferi B31 and B. afzelii BO23. The
B. garinii SZ strain is highly pathogenic and can trigger
multi-system pathological damage in mice. Ninety days
after infection, the differences in spirochete burden were
evident in terms of the persistence and tissue tropism.
Infections could persist up to 6 months.
Further studies using experimental infections and
transmission with additional clinical isolates may be
conducted to analyze vector competency of Dermacentor
spp. for this pathogen and to clarify the potential role of
genotypic variation of B. burgdorferi in the pathogenicity
of Lyme disease.
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